International Cannabis Weekly: 330

2023 SPOTLIGHT: SWITZERLAND SETTING NEW LEGAL AND SCIENTIFIC STANDARDS

Switzerland’s pioneering cannabis pilot project has developed into Europe’s most advanced and accessible adult-use framework throughout 2023.

READ MORE  »

POLITICIANS IN UKRAINE VOTE TO LEGALISE MEDICAL CANNABIS

READ MORE »

20,000 SIGNATURES COLLECTED IN ITALY FOR CANNABIS LEGALISATION REFERENDUM

READ MORE »

• Health professionals in the UK have a favourable stance on medical cannabis, recent survey reveals.
• 2023 Spotlight: France’s struggle to advance medical cannabis initiatives takes centre stage.
• European Cannabis Stocks in 2023: MGC’s Artemic approved in Saudi Arabia & Panaxia stock skyrockets.
• Cannamedical Cannabis Survey 2023/24 launched as part of current initiative to improve patient care.
• Somaí Pharmaceuticals and Canify partner to launch cannabinoid-based product line in Germany.
• Belgium’s Florapoint CBD outlets have rebranded as the Green Grown Cannabis store.

READ 2023 STOCK REPORT »

• Florida GOP Senator introduces bill for tax relief in the medical cannabis industry.
• Nebraska activists highlight progress of medical cannabis legalisation petition in 16 counties.
• Delaware legislation aims to broaden medical cannabis access in anticipation of adult-use sales rollout.
• Federal authorities and cannabis industry extend lawsuit deadline, mutually agreeing on challenge to prohibition.
• Wisconsin proposals seek cannabis legalisation despite existing federal prohibition.
• Six synthetic cannabinoids classified as Schedule 1 to prevent ‘imminent hazard to public safety’.

Europe’s adult-use industry is still in its very early stages; however, significant developments continue to be made on a consistent basis in various countries across the region.

Though only a small number of countries have reached advanced stages of developing systems for adult-use legalisation, there is already some variation in the approaches taken.

DOWNLOAD FREE REPORT »

• Organigram’s Q4 revenue soars with pre-rolls and edibles, securing #2 market position.
• Alberta’s provincial government has decided to allow cannabis sales at adults-only events.
• Licensed retailers seek inclusion in Ontario’s government monopoly over mail-order cannabis.
• Health Canada approves innovative EEG-driven research model for exploring non-therapeutic effects of cannabis.
• Shiny Health & Wellness finalises acquisition deal with Stash & Co., strengthening their business partnership.
• Motif Labs appoints new Chief Manufacturing Officer to strengthen operational leadership team.

• São Vicente’s first medicinal cannabis collaboration emphasises the significance of public awareness in health initiatives.
• Colombia’s President condemns senate for halting cannabis legalisation, alleging it ‘favours drug traffickers’.
• Argentina gives the green light to incorporating seeds and hemp into flours and oils for various culinary applications.
• Colombia-based Blueberries Medical unveils C$2 million private placement without brokers.

• CannMart to facilitate inaugural international export of medical cannabis to Australia.
• New Zealand’s Greenfern Industries has been given the green light for its first commercial cannabis harvest.
• Vote on the future of Epsilon chairman is cancelled, as the company calls in administrator.
• Japan’s health ministry bans the sale of 38 products with cannabis-like compounds.

• Ghana’s parliament has approved legislation to regulate the production of cannabis for industrial use.
• Authorities in South African province pledge support for newly licensed hemp growers.